Mediwhale

Mediwhale

Private
Gangnam-gu, SeoulHealthcare & Life Scienceshttps://www.mediwhale.com

Last Round

Series C

Mar 31, 2026

Total Funding Raised

$34.3M

Momentum Score

50 /100

Company Overview

Mediwhale is a healthcare technology company that specializes in artificial intelligence-driven diagnostics to assess health risks via retinal scans for the early detection of cardiovascular, kidney, and eye diseases, facilitating preventive care in primary care environments.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Healthcare Analytics, Medical Imaging

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

AI retina scanretinal AIsoftware as a medical deviceSaaMDcardiovascular risk assessmentAI diagnosticsmedical imaging AInon-invasive diagnosticskidney disease detectionpreventive health screeningsystemic disease predictionretinal imagingprimary care diagnosticsretinal biomarkerhealth reimbursementFDA clearanceCE markbiological age estimation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mediwhale Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mediwhale Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CMar 31, 2026
Series B ExtensionSep 25, 2024
Series AApr 18, 2023

Key People

Founding team and executive leadership

Kevin Choi

CEO

Executive Team

Nina Nahyeon Shin

Chief Operating Officer (COO), COO

Executive Team

Young Lee

Chief Product Officer

Executive Team

Mediwhale Investors

Notable investors and investment history

InvestorRounds
Hana VenturesSeries C
IMM InvestmentSeries C
KB InvestmentSeries C
HeartX FundSeries A
Premier PartnersSeries C
Mirae Asset SecuritiesSeries B Extension
QUAD Investment ManagementSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 53% MoM to 10.8K.

  • Mar 31, 2026

    $13.3M round completed.

Mediwhale Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mediwhale Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mediwhale's valuation, stock price, and market status.

Firmographic Details

HeadquartersGangnam-gu, Seoul
Employee Range44
Year Founded2016
Last FundingMar 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.